ORIFARM A/S: Financial statements 2023
CVR: 26058708
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ORIFARM A/S (CVR 26058708) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 1,575,946,000 and a net result of DKK 18,874,000 compared with DKK 9,941,000 the year before. That is an increase of 12.2% compared with the year before. The profit margin was 1.2%. Equity in the 2023 report amounted to DKK 76,256,000. The solvency ratio was 25.3%. The company had 37 employees in the financial year.
- Revenue
- DKK 1,575,946,000
- Gross Profit
- DKK 27,635,000
- Profit/Loss
- DKK 18,874,000
- Equity
- DKK 76,256,000
- Total Assets
- DKK 301,842,000
- Employees
- 37
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 1.6B | 27.6M | 18.9M | 76.3M | 37 |
| 2022 | 1.4B | 20.2M | 9.9M | 57.4M | 34 |
| 2021 | 1.5B | 19.5M | 8.2M | 47.4M | 40 |
| 2020 | 1.2B | 35.4M | 6.6M | 42.3M | 42 |
| 2019 | 1.2B | 31.4M | 5.1M | 35.7M | 38 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ORIFARM A/S has published its annual report for 2022. Revenue came to DKK 1,404,798,000, and the net result was DKK 9,941,000.
About ORIFARM A/S
ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.